【Abstract】 Chronic kidney disease (CKD) has become one of the common chronic noncommunicable diseases in the world. Hyperuricemia (HUA) is not only a marker of kidney damage but also an independent risk factor for CKD. CKD and HUA increase cardiovascular risk and mortality risk associated with CKD progression and metabolic syndrome. Indepth study of CKD patients with HUA have a great significance.